Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease

Conclusions
Moderate and severe CLD increases 1- and 3-year mortality after TAVR. Although functional status and quality of life were improved in CLD at 1 and 3 years after TAVR, a favorable health benefit was only achieved in selected patients. (Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement; NCT01240902)

Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 20, 2017 Category: Cardiology Authors: Crestanello, J. A., Popma, J. J., Adams, D. H., Deeb, G. M., Mumtaz, M., George, B., Huang, J., Reardon, M. J. Tags: Structural Source Type: research